Raptor Pharmaceuticals Corp. (Nasdaq: RPTP) narrowed second quarter losses more than expected to 20 cents per share from losses of 43 cents per share in the year ago period as revenue surged prompting the company to lift its full year revenue outlook. The stock price leaped $2.32 to close at $10.56.
Raptor Pharmaceuticals narrows losses
August 08, 2014 at 17:34 PM EDT
